Milton Boyer serves as our SVP and Business Unit Leader for Drug Product Manufacturing and brings more than 25 years of experience within the chemical and pharmaceutical industry with assignments of increasing responsibility in technical, commercial, and executive roles. Mr. Boyer joined AMRI in 2014 upon the acquisition of Oso Biopharmaceuticals where he served as President & CEO and was also a member of the board of directors. For the past 18 years his assignments have been focused in contract manufacturing for both pharmaceuticals and biopharmaceuticals, developing experience and expertise for both drug substance and drug product. He holds a B.S. in Chemistry/Physics and an M.S. in Biochemistry.
Mr. Boyer is very active in trade groups and educational institutions that support the pharmaceutical and biopharmaceutical industry. He currently serves on the External Advisory Board for the Department of Chemistry and Biology for the University of New Mexico. He has also served on the Board of Directors of Drugs, Chemicals & Allied Trades (DCAT) and currently serves on the Executive Committee as Vice President and Treasurer. He has also been a member of other professional organizations, including the American Association of Pharmaceutical Scientists (AAPS), the Parenteral Drug Association (PDA) and the Society of Chemical Manufacturers and Associates (SOCMA).